Moneycontrol PRO
HomeNewsStocks

Stocks

Jump to
  • Bharat Forge shares settle 4% higher on reports of Army order

    Bharat Forge shares settled 4% higher at Rs 1,296 apiece on the NSE, after hitting an intraday high of Rs 1,311, up 5.44%.

  • Eli Lilly allows Cipla to sell weight loss drug 'Tirzepatide' under new brand in India

    Eli Lilly allows Cipla to sell weight loss drug 'Tirzepatide' under new brand in India

    Under the agreement, Cipla will market the drug under a new brand name, Yurpeak, while Lilly continues to sell it as Mounjaro, launched earlier this year.

  • Laurus Labs posts Rs 195 crore net profit in Q2FY26 led by CDMO, generics momentum

    Laurus Labs posts Rs 195 crore net profit in Q2FY26 led by CDMO, generics momentum

    The surge in profitability was underpinned by a 35% rise in revenues to ₹1,653 crore and a 136% jump in EBITDA to ₹429 crore, lifting margins to 26% from 14.9% a year earlier.

  • HUL shares up 2% as September quarter results beat estimates, FMCG index rises 1%

    HUL shares up 2% as September quarter results beat estimates, FMCG index rises 1%

    FMCG major posted a 4 percent year-on-year increase in consolidated net profit for the July-September quarter (Q2 FY26) at Rs 2,694 crore.

  • Manappuram, Muthoot Finance decline up to 3% as gold prices fall for three days

    Manappuram, Muthoot Finance decline up to 3% as gold prices fall for three days

    With India’s festival season nearing its end, seasonal physical demand is expected to taper off, leaving prices vulnerable.

  • Ruchir Sharma: Why gold and stocks are partying together

    Ruchir Sharma: Why gold and stocks are partying together

    These booms are connected, but not in the way you may have heard 

  • HDFC Bank shares hit fresh high as Q2 results exceed expectations; brokerages raise price targets

    HDFC Bank shares hit fresh high as Q2 results exceed expectations; brokerages raise price targets

    HDFC Bank share has advanced over 3 percent in the past four sessions.

  • RPG Life Sciences eyes strategic acquisitions as cash-rich balance sheet fuels expansion plans

    RPG Life Sciences eyes strategic acquisitions as cash-rich balance sheet fuels expansion plans

    The pharma firm, part of the RPG Group, is leveraging its robust balance sheet to explore inorganic growth across APIs, formulations, and emerging therapeutic trends.

  • Strides Pharma ties-up with Bangladesh's Incepta to launch long-acting contraceptive in Africa

    Strides Pharma ties-up with Bangladesh's Incepta to launch long-acting contraceptive in Africa

    The WHO prequalification of the product, developed by Incepta with support from the Children’s Investment Fund Foundation (CIFF) and the Gates Foundation, breaks the single-source supply chain for DMPA-SC, enabling health systems to procure the drug at more affordable prices.

  • Supreme Court dismisses Roche's petition to restrain Natco from selling Risdiplam generic

    Supreme Court dismisses Roche's petition to restrain Natco from selling Risdiplam generic

    A bench comprising Justice PS Narasimha and Justice Atul S Chandurkar declined to interfere with the Delhi High Court's order, observing that it was only an interim order.

  • Biocon Biologics, Civica ink deal to launch low-cost insulin glargine in US

    Biocon Biologics, Civica ink deal to launch low-cost insulin glargine in US

    Under the multi-year agreement, Biocon Biologics will manufacture and supply insulin glargine to Civica, which will commercialize the product under its own label.

  • Zee Entertainment shares drop to 5-month low as Q2 net profit declines 63%

    Zee Entertainment shares drop to 5-month low as Q2 net profit declines 63%

    Shares of Zee Entertainment Enterprises dropped to an intraday low of Rs 105.1 per share on the NSE, down 3.85 percent.

  • Asian Paints, Kansai Nerolac, other paint stocks rise up to 5% on decline in crude oil

    Asian Paints, Kansai Nerolac, other paint stocks rise up to 5% on decline in crude oil

    Asian Paints shares rose nearly 6 percent intraday, emerging as the top gainer on the Nifty 50 index.

  • Axis Bank Q2 results propel Bank Nifty past 57,200; analysts say 57,500 is next resistance

    Axis Bank Q2 results propel Bank Nifty past 57,200; analysts say 57,500 is next resistance

    At least eight of the 40 brokerages tracking Axis Bank raised their price targets following the results.

  • MTAR Tech, BEML, HAL rise up to 4% on report of govt's plan to boost defence spending in FY26

    MTAR Tech, BEML, HAL rise up to 4% on report of govt's plan to boost defence spending in FY26

    Shares of defence firms rose on reports that the government is likely to make additional fund allocations for the defence sector.

  • Sobha, DLF, other real estate shares rise up to 6% on optimism over Fed rate cut

    Sobha, DLF, other real estate shares rise up to 6% on optimism over Fed rate cut

    Nifty Realty index rose over 3 percent, recovering from the previous day’s losses, as investors cheered comments from Fed Chair Jerome Powell indicating possible monetary easing.

  • LG Electronics India shares fall 5% from day's high on market debut day; check target price by brokerages

    LG Electronics India shares fall 5% from day's high on market debut day; check target price by brokerages

    LG Electronics India shares started trading at Rs 1,715, surging 50.43 percent from the issue price on the BSE.

  • Jupiter Life Line in Rs 1,400-crore expansion push in Maharashtra, to double capacity by 2029

    Jupiter Life Line in Rs 1,400-crore expansion push in Maharashtra, to double capacity by 2029

    As demand for quality specialist care grows in underserved urban clusters, the hospital chain plans increase the bed count from 1,061 to 2,500, CEO Ankit Thakker tells Moneycontrol

  • Business in the Week Ahead (October 13- 17, 2025) 

    Business in the Week Ahead (October 13- 17, 2025) 

    The upcoming week features key Q2 earnings from major Indian companies and important macro data like India’s inflation and WPI manufacturing figures. Also, a look at global data from the US, UK, and Euro area which can likely influence markets

  • Tata Motors demerger record date next week; how will it affect fundamentals? Should you buy, sell or hold?

    Tata Motors demerger record date next week; how will it affect fundamentals? Should you buy, sell or hold?

    Equity shares to be issued by TML Commercial Vehicles Ltd (TMLCV) will be listed on both the BSE and NSE.

  • Tata Communications, Yes Bank, Reliance Power shares gain up to 14% on high volumes

    Tata Communications, Yes Bank, Reliance Power shares gain up to 14% on high volumes

    Tata Communications rose over 14 percent to an intraday high of Rs 1,938.90 apiece on the NSE.

  • SpiceJet shares gain 7% as airline adds 3 new aircraft to its operational fleet

    SpiceJet shares gain 7% as airline adds 3 new aircraft to its operational fleet

    Shares of Spicejet Ltd touched an intraday high of Rs 35.59 per share on the BSE, rising 7.56 percent.

  • Roche faces setback as Delhi high court clears Natco Pharma's low cost generic Risdiplam

    Roche faces setback as Delhi high court clears Natco Pharma's low cost generic Risdiplam

    The court dismissed Roche’s plea for an injunction, citing public interest and the need for affordable access to the drug, which currently retails at over ₹600,000 per bottle under Roche’s brand name Evrysdi.

  • TCS shares trade flat ahead of Q2 results; here's what brokerages expect

    TCS shares trade flat ahead of Q2 results; here's what brokerages expect

    Analysts expect company to report 1.3% YoY growth in revenue and 6% YoY growth in profit

  • Brightcom, IFCI, Jai Corp shares rise up to 11% on circuit change announcement

    Brightcom, IFCI, Jai Corp shares rise up to 11% on circuit change announcement

    Shares of Brightcom Group gained 15.79 percent to hit an intraday high of Rs 15.11 on the NSE. The stock opened with a gain of 7.28 percent, recovering after three sessions of decline.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347